Physician profile
Dylan Jerome Watson
NPI 1689802225
$3,793.24
in general payments reported to CMS, 2019-2025
10 companies · $512 in 2025
The $512 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,363 · 2020: $112 · 2021: $1,494 · 2022: $67.24 · 2023: $200 · 2024: $44.29 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $450 · Food and Beverage: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $450.00 |
| Food and Beverage | $306.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,076.94 | 2019-2025 | Kincise, Emphasys, Actis |
| Stryker Corporation | $575.89 | 2019-2021 | |
| Encore Medical, LP | $460.64 | 2021 | |
| Smith+Nephew, INC. | $334.05 | 2021-2025 | Real Intelligence, Redapt, Journey II |
| Depuy Synthes Sales INC. | $130.20 | 2019 | |
| Ferring Pharmaceuticals INC. | $72.26 | 2023 | Euflexxa |
| Abbvie INC. | $60.63 | 2021-2022 | |
| Heraeus Medical, LLC. | $34.97 | 2022 | |
| Horizon Therapeutics Plc | $32.13 | 2019 | |
| Conformis, INC. | $15.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.